Search Within

Francesca Orlandi

Formats
  1. Journal Article (6)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (8)
  2. GSK Faculty (8)
  3. Immunology Program Faculty (8)
  4. Melanoma and Immunotherapeutics Service (8)
  5. Sloan Kettering Institute Faculty (8)
  6. Solid Tumor Oncology Division (8)

More Groups

People
  1. Alan Houghton (8)
  2. Jedd Wolchok (8)
  3. Polly Gregor (5)
  4. Geoffrey Ku (3)
  5. Hao Li (3)
  6. Humilidad Gallardo (3)

More People

Years
  1. 2011 (1)
  2. 2009 (3)
  3. 2007 (3)
  4. 2006 (1)
  5. 2005 (1)
Publications
  1. Cancer Immunity (2)
  2. Vaccine (2)
  3. Cancer Research (1)
  4. Clinical Cancer Research (1)
  5. Cytotherapy (1)
  6. FASEB Journal (1)

More Publications

Publishers
  1. Academy of Cancer Immunology (2)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Science Ltd. (1)
  6. Federation of American Societies for Experimental Biology (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination of epitope-optimized DNA vaccination and passive infusion of monoclonal antibody against HER2/neu leads to breast tumor regression in mice
    Journal Article

    Orlandi, F.; Guevara-Patiño, J. A.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.; Gregor, P. D.
    Vaccine (2011)

    Fulltext@MSK | Save
  • Cytokine changes in castrate metastatic prostate cancer (CPMC) patients (pts) treated with ipilimumab (Ipi)
    Meeting Abstract

    Yuan, J.; Orlandi, F.; Jefferson, M.; Li, H.; Gallardo, H.; Ku, G.; Wolchok, J.; Scher, H.; Allison, J.; Slovin, S. F.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Safety and immunogenicity of gp100 DNA vaccines in patients with melanoma
    Meeting Abstract

    Yuan, J.; Ku, G. Y.; Gallardo, H. F.; Orlandi, F.; Manukian, G.; Rasalan, T.; Li, H.; Xu, Y.; Vyas, S.; Mu, Z.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Gallardo, H.; Orlandi, F.; Manukian, G.; Rasalan, T.; Xu, Y.; Li, H.; Vyas, S.; Mu, Z.; more...
    Cancer Immunity (2009)

    Fulltext@MSK | Save
  • Antibody and CD8+ T cell responses against HER2/neu required for tumor eradication after DNA immunization with a Flt-3 ligand fusion vaccine
    Journal Article

    Orlandi, F.; Venanzi, F. M.; Concetti, A.; Yamauchi, H.; Tiwari, S.; Norton, L.; Wolchok, J. D.; Houghton, A. N.; Gregor, P. D.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes
    Journal Article

    Houghton, C. S. B.; Engelhorn, M. E.; Liu, C.; Song, D.; Gregor, P.; Livingston, P. O.; Orlandi, F.; Wolchok, J. D.; McCracken, J.; Houghton, A. N.; more...
    Vaccine (2007)

    Fulltext@MSK | Save
  • Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag
    Journal Article

    Felicetti, P.; Mennecozzi, M.; Barucca, A.; Montgomery, S.; Orlandi, F.; Manova, K.; Houghton, A. N.; Gregor, P. D.; Concetti, A.; Venanzi, F. M.
    Cytotherapy (2007)

    Fulltext@MSK | Save
  • Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma
    Journal Article

    Liao, J. C. F.; Gregor, P.; Wolchok, J. D.; Orlandi, F.; Craft, D.; Leung, C.; Houghton, A. N.; Bergman, P. J.
    Cancer Immunity (2006)

    Fulltext@MSK | Save
  • DNA immunization against HER2/neu+ breast cancer: Evidence for a role of both antibody and T cell for optimal tumor eradication
    Meeting Abstract

    Orlandi, F.; Venanzi, F. M.; Concetti, A.; Yamauchi, J.; Wolchok, J. D.; Norton, L.; Houghton, A. N.; Gregor, P. D.
    FASEB Journal (2005)

    Fulltext@MSK | Save